Results 191 to 200 of about 10,600 (216)

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

Nature Reviews Immunology, 2021
John S Tregoning, Ziyin Wang, Benjamin F Pierce   +2 more
exaly  

Zoster Vaccine Recombinant, Adjuvanted

2020
openaire   +1 more source

Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety

Journal of Nephrology, 2023
Martino FK, Pini S, Scaparrotta G, Schirinzi M, Gnappi M, Fragasso A, Zanella R, Naso E, De Giorgi ML, Carraro G, Nalesso F, Calò LA.   +11 more
openaire   +2 more sources

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

Nature Medicine, 2021
Julio S Solís Arce, Shana S Warren, Niccolò F Meriggi   +2 more
exaly  

Looking beyond COVID-19 vaccine phase 3 trials

Nature Medicine, 2021
Jerome H Kim, Florian Marks, John D Clemens   +2 more
exaly  

Herpes Zoster and Varicella Encephalitis Following the Recombinant Zoster Vaccine

Cutis
Mallory, Pane, Catherine, Harrell, Stuart C, Pickell   +2 more
openaire   +2 more sources

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Nature Medicine, 2021
Xuping Xie, Jianying Liu, Jing Zou
exaly  

A global survey of potential acceptance of a COVID-19 vaccine

Nature Medicine, 2020
Jeffrey V Lazarus, Adam Palayew, Heidi J Larson   +2 more
exaly  

Breakthrough herpes zoster risk after recombinant zoster vaccination

Vaccine
Shih-Wei Lai, Kuan-Fu Liao
openaire   +1 more source

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

Ca-A Cancer Journal for Clinicians, 2007
Diane M Harper, Robert A Smith, Francisco Garcia   +2 more
exaly